Date: 31.7.2023
Scientists have found a way to use nanotechnology to create a 3D "scaffold" to grow cells from the retina – paving the way for potential new ways treating a common cause of blindness.
Researchers, led by Professor Barbara Pierscionek from Anglia Ruskin University (ARU), have been working on a way to successfully grow retinal pigment epithelial (RPE) cells that stay healthy and viable for up to 150 days. RPE cells sit just outside the neural part of the retina, and when damaged, can cause vision to deteriorate.
It is the first time this technology, called "electrospinning," has been used to create a scaffold on which the RPE cells could grow, and could revolutionize treatment for one of age-related macular degeneration, one of the world's most common vision complaints.
When the scaffold is treated with a steroid called fluocinolone acetonide, which protects against inflammation, the resilience of the cells appears to increase, promoting growth of eye cells. These findings are important in the future development of ocular tissue for transplantation into the patient's eye.
Age-related macular degeneration (AMD) is a leading cause of blindness in the developed world and is expected to increase in the coming years due to an aging population. Recent research has predicted that 77 million people in Europe alone will have some form of AMD by 2050.
Image source: Egbowon et al. (2023), Material & Design.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Life Sciences Search engine - Huge database of genome, protein, gene, genome project, ..
Science Magazine
Fluorous lipopeptides act as highly effective antibiotics for multidrug-resistant pathogens
New organoid culture method can verify human toxicity of nanomaterials